Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BLRX
BLRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BLRX News
BioLineRx (BLRX) Q1 2026 Earnings Transcript
2d ago
NASDAQ.COM
BioLineRx Initiates Phase 1/2a Trial for GLIX1 in Glioblastoma
4d ago
PRnewswire
BioLineRx Q1 Earnings Exceed Expectations
4d ago
seekingalpha
BioLineRx Scheduled to Announce Q1 Earnings
5d ago
seekingalpha
BioLineRx and Hemispherian to Present GLIX1 Abstracts at ASCO 2026
May 22 2026
PRnewswire
BioLineRx and Hemispherian Present GLIX1 Research Findings
May 22 2026
Newsfilter
BioLineRx and Hemispherian Present New GLIX1 Data
May 22 2026
Yahoo Finance
BioLineRx to Release Q1 Financial Results on May 27
May 20 2026
PRnewswire
New Preclinical Data Enhances GLIX1 Efficacy
May 19 2026
PRnewswire
BioLineRx Partners with Hemispherian for Glioblastoma Trial
Apr 28 2026
stocktwits
BioLineRx Initiates First-in-Human Trial of GLIX1 for GBM
Mar 26 2026
PRnewswire
BIOLINERX LAUNCHES PHASE 1/2A CLINICAL TRIAL OF GLIX1 FOR GLIOBLASTOMA (GBM) TREATMENT
Mar 26 2026
moomoo
BioLineRx Initiates GLIX1 Clinical Trial for Glioblastoma
Mar 23 2026
PRnewswire
BioLineRx to Initiate GLIX1 Clinical Trial for Glioblastoma
Mar 23 2026
Newsfilter
BioLineRx Reports FY EPS Beat Despite Revenue Plunge
Mar 23 2026
seekingalpha
BIOLINE RX LTD SET TO LAUNCH PHASE 1/2A CLINICAL TRIAL OF GLIX1 FOR GLIOBLASTOMA TREATMENT BY MONTH'S END
Mar 23 2026
moomoo
Show More News
